June 3, 2020: On February 11, 2020, HHS issued a message (PDF, 162 KB) to state stakeholders Keeping antiviral drug items (Tamiflu and Relenza) about added expiry courting extensions for adequately held product. “…Based on FDA's evaluation of scientific info, FDA has concluded for crisis responses that, provided the products https://sergiosfvfi.collectblogs.com/78076445/listing-expiration-date-an-overview